首页 / 产品 / 抗体 / 一抗

Rabbit Polyclonal KA1 Antibody

  • 中文名: KA1抗体
  • 别    名: EAA1; GluK4; GRIK; Grik4; KA1
货号: IPDX23105
Price: ¥1180
数量:
大包装询价

验证与应用

应用及物种
WB 1/500-1/1000 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC 咨询技术 Human,Mouse,Rat
ICC 技术咨询 Human,Mouse,Rat
FCM 咨询技术 Human,Mouse,Rat
Elisa 咨询技术 Human,Mouse,Rat

产品详情

AliasesEAA1; GluK4; GRIK; Grik4; KA1
Entrez GeneID2900
WB Predicted band sizeCalculated MW: 107 kDa; Observed MW: 107 kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman,Mouse,Rat
ImmunogenRecombinant protein of human KA1
FormulationPurified antibody in TBS with 0.05% sodium azide,0.05%BSA and 50% glycerol.

+ +

参考文献

以下是关于KA1(GluK1受体亚基)抗体的3篇代表性文献示例,基于典型研究方向和内容整理而成:

---

1. **文献名称**:*Differential localization of kainate receptor subunits GluK1 and GluK2 in the rat hippocampus*

**作者**:Darstein M, et al.

**摘要**:本研究利用KA1特异性抗体,通过免疫组化和共聚焦显微镜技术,揭示了GluK1受体亚基在大鼠海马CA3区的突触后特异性定位,并探讨其在突触可塑性和神经元兴奋性调控中的作用。

---

2. **文献名称**:*GluK1-containing kainate receptors modulate neurodegenerative pathways in Alzheimer’s disease models*

**作者**:Carta M, et al.

**摘要**:通过Western blot和免疫荧光技术,文章发现阿尔茨海默病模型小鼠大脑中GluK1受体表达异常升高,KA1抗体的应用帮助验证了GluK1与β-淀粉样蛋白病理的关联,提示其可能成为治疗靶点。

---

3. **文献名称**:*Antibody-based targeting of GluK1 receptors ameliorates seizure activity in a mouse model of epilepsy*

**作者**:Vincent P, Mulle C.

**摘要**:研究开发了一种高特异性KA1抗体,用于阻断GluK1受体功能。实验表明,该抗体可显著降低癫痫模型小鼠的发作频率,为抗癫痫药物研发提供了新策略。

---

**注**:以上文献信息为示例性质,实际引用需根据具体研究核实原文。如需真实文献,建议通过PubMed或Google Scholar检索关键词(如“GluK1 antibody”或“KA1 receptor study”)。

背景信息

The KA1 antibody specifically targets the KA1 subunit, a critical component of the kainate-type glutamate receptors (KARs), which belong to the ionotropic glutamate receptor family. These receptors mediate excitatory neurotransmission and synaptic plasticity in the central nervous system (CNS). The KA1 subunit (encoded by the *GRIK4* gene) typically forms heteromeric complexes with KA2 or other KAR subunits, predominantly localizing in regions such as the hippocampus, cortex, and cerebellum. Unlike other KAR subunits, KA1 exhibits high affinity for glutamate and plays dual roles in both postsynaptic depolarization and presynaptic modulation of neurotransmitter release. Dysregulation of KA1 has been implicated in neurological and psychiatric disorders, including epilepsy, schizophrenia, and autism spectrum disorders. KA1 antibodies are widely utilized in neuroscience research to investigate receptor distribution, expression levels, and functional interactions through techniques like immunohistochemistry, Western blotting, and immunoprecipitation. These studies aim to elucidate KA1's role in disease mechanisms and its potential as a therapeutic target. Additionally, KA1 antibodies contribute to preclinical drug development by enabling the validation of compounds targeting KAR signaling pathways. Their application bridges basic research and clinical exploration, offering insights into synaptic dysfunction and novel treatment strategies.

客户数据及评论

折叠内容

大包装询价

×